Potential Pitfalls in Cannabis and CBD Marketing
This presentation offered a discussion of recent Food and Drug Administration (FDA) and Federal Trade Commission (FTC) enforcement actions, along with state and federal litigation, and provided updates on recent legislation.
This Is an ANA Member Exclusive
Access to this item is reserved for ANA members only.
Log in
Already have an account? The industry's best insights and resources await:
No Account?
Use your business email address to create your free account; if you're a member through your company, we'll know.
Members can access their benefits as soon as they sign up and log in.
Not a Member?
You can still create a free account to access the latest from our online publication, ANA Magazine, receive content and special event offers through our newsletters, get breaking industry updates, and so much more.
The content you're trying to see is available to:
- ANA Client-Side Marketer Tier Members
- Platinum Tier Members
- Gold Tier Members
- Silver Tier Members
- Individual Members
Discover everything the ANA can do to help drive growth for your organization. Connect with our membership team.